Abzu ApS
Abzu uses explainable AI to develop safer RNA therapeutics.
Overview
- 6
- Employees
- Unknown
- Revenue
- 2018
- Founded
Key Decision Makers
Lykke Pedersen
Chief Pharma Officer
Victor Galindo
Co-founder and CEO
Maria Jacobsen
Operations & Administration Lead
Kevin Broløs
Co-founder and Mad Scientist
+6 more contacts in Funnelfeedr
Description
Abzu is a biotechnology company founded in 2018 that specializes in applying explainable artificial intelligence to the field of RNA therapeutics. With a small, expert team of nine employees based in Copenhagen and Barcelona, the company focuses on designing safer and more effective siRNA and ASO dr...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- APS
- VAT Number
- DK39248530
Decision Makers
10 contacts in FunnelfeedrLykke Pedersen
Chief Pharma Officer
Victor Galindo
Co-founder and CEO
Maria Jacobsen
Operations & Administration Lead
Kevin Broløs
Co-founder and Mad Scientist
Kasper Sommer
CFO
Martin Kerr
Business Development + Pharma Partnerships
Other Contacts
Christine Søholm Hansen
Bioinformatician
Meera Machado
Data Person + Physicist
Jim Shur
Software Developer
Disa Tehler
Head of RNA Therapeutics
Similar Companies
20 similar companies in Funnelfeedr
Orbis Medicines ApS
29 employeesOrbis Medicines develops oral macrocycle drugs using an AI-powered platform.
INCEPTIVE NUCLEICS INC
Building foundation models of life for superior drug design.
Skape Bio ApS
12 employeesAI-driven biotechnology company designing novel miniproteins for GPCR drug discovery.
CONTERA PHARMA A/S
19 employeesDanish biotech company developing innovative RNA therapeutics for neurological disorders.
Neumirna Therapeutics ApS
9 employeesDeveloping miRNA-based therapies to treat complex neurological disease root causes.
Abzu ApS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo